Bruker Corp.
- BRKR · Nasdaq
- Laboratory Analytical Instruments
- Billerica, MA
- 11,085 employees
- CIK 0001109354
Updated from SEC filings through
Top things to know
Executives
- Frank H. Laukien Bruker’s President and CEO 8-K, 2026-11-04
- Burkhard Prause PRES. & CEO, BRUKER BEST 4, 2026-08-18
- Gerald N. Herman EXECUTIVE VICE PRESIDENT, CFO 4, 2026-08-18
- Juergen Srega PRESIDENT CALID 4, 2026-08-18
- Wolfgang Pusch President BMID Group 4, 2026-08-18
- Thomas Bures Chief Accounting Officer 4, 2026-08-18
What leadership is saying
“Bruker drives significant advances in post-genomic drug discovery and disease biology research, from proteoforms to glycobiology, and from functional protein interactions to spatial biology. These deeper insights into molecular, cell and tissue biology are foundational for successful drug development and useful AI frontier models. Together with strong growth-drivers in infectious disease diagnostics, and in deep-tech and semiconductor metrology, we are poised for growth accel”
Earnings press release (8-K Ex. 99.1), filed November 4, 2026
Bruker Corp is a U.S. public company in laboratory analytical instruments (SIC 3826), headquartered in Billerica, MA. It trades as BRKR on Nasdaq. Revenue was $3.4B in the fiscal year ending December 31, 2025, +2.1% from the year before. It reported about 11,085 employees. Frank H. Laukien is Bruker’s President and CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.4B 10-K, 2026-02-27 | $3.4B 10-K, 2026-02-27 | $3.0B 10-K, 2026-02-27 | $2.5B 10-K, 2025-03-03 | $2.4B 10-K, 2024-02-29 |
| Operating income | $68.2M 10-K, 2026-02-27 | $253M 10-K, 2026-02-27 | $437M 10-K, 2026-02-27 | $433M 10-K, 2025-03-03 | $413M 10-K, 2024-02-29 |
| SG&A | $947M 10-K, 2026-02-27 | $894M 10-K, 2026-02-27 | $729M 10-K, 2026-02-27 | $607M 10-K, 2025-03-03 | $561M 10-K, 2024-02-29 |
| Net income | -$8.6M 10-K, 2026-02-27 | $113M 10-K, 2026-02-27 | $427M 10-K, 2026-02-27 | $297M 10-K, 2025-03-03 | $277M 10-K, 2024-02-29 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Frank H. Laukien | Bruker’s President and CEO | 8-K, 2026-11-04 |
| Burkhard Prause | PRES. & CEO, BRUKER BEST | 4, 2026-08-18 |
| Gerald N. Herman | EXECUTIVE VICE PRESIDENT, CFO | 4, 2026-08-18 |
| Juergen Srega | PRESIDENT CALID | 4, 2026-08-18 |
| Wolfgang Pusch | President BMID Group | 4, 2026-08-18 |
| Thomas Bures | Chief Accounting Officer | 4, 2026-08-18 |
| Mark Munch | EXEC VP&PRES BRUKER NANO INC. | 4, 2026-09-16 |
| Cynthia M. Friend, Ph.D. | Board member (per proxy) bio: Class II director | DEF 14A, 2026-04-10 |
| Hermann F. Requardt, Ph.D. | Board member (per proxy) bio: Class II director | DEF 14A, 2026-04-10 |
| John J. (Jack) Phillips | Board member (per proxy) bio: Class II director | DEF 14A, 2026-04-10 |
| Laura A. Francis | Board member (per proxy) bio: Class II director | DEF 14A, 2026-04-10 |
| Thierry L. Bernard | Board member (per proxy) bio: Class III director | DEF 14A, 2026-04-10 |
What Bruker Corp does
We are a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable our customers to explore life and materials at microscopic, molecular and cellular levels. Many of our products are used to detect, measure and visualize structural characteristics of chemical, biological and industrial material samples.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 151.7 million (as of July 29, 2025) | 10-Q, August 6, 2025 |
|---|---|---|
| Public float | $4.3B (as of June 30, 2025) | 10-K, February 27, 2026 |
| Reportable segments | 4 (period ending September 30, 2026) | 10-Q, November 5, 2026 |
| Latest proxy statement | Meeting May 21, 2026 (filed April 10, 2026) | DEF 14A, April 10, 2026 |
| Auditor | PricewaterhouseCoopers LLP (Boston, Massachusetts) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| September 15, 2026 | Mark Munch EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $106K | Form 4, September 16, 2026 |
| August 17, 2026 | Wolfgang Pusch President BMID Group | Sale | 3,473 | $198K | Form 4, August 18, 2026 |
| August 14, 2026 | Mark Munch EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $115K | Form 4, August 18, 2026 |
| July 15, 2026 | Mark Munch EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $121K | Form 4, July 16, 2026 |
| June 15, 2026 | Mark Munch EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $110K | Form 4, June 16, 2026 |
| May 15, 2026 | Mark Munch EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $88K | Form 4, May 18, 2026 |
| April 15, 2026 | Mark Munch EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $80K | Form 4, April 16, 2026 |
| March 13, 2026 | Mark Munch EXEC VP&PRES BRUKER NANO INC. | Sale | 2,000 | $71K | Form 4, March 16, 2026 |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 8.01 Other events
- 8-K filed 2026-11-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-29
- Item 8.01 Other events
- 8-K filed 2026-08-14
- Item 8.01 Other events
- 8-K filed 2026-08-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-07-30
- Item 8.01 Other events
- 8-K filed 2026-05-21
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-15
- Item 8.01 Other events
- 8-K filed 2026-05-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-04-28
- Item 8.01 Other events
Frequently asked questions about Bruker Corp
- What does Bruker Corp do?
- In its own words, from Item 1 of its 10-K: "We are a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable our customers to explore life and materials at microscopic, molecular and cellular levels. Many of our products are used to detect, measure and visualize structural characteristics of chemical, biological and industrial material samples."
- What is Bruker Corp's revenue?
- $3.4B for the fiscal year ending December 31, 2025, from its 10-K filed February 27, 2026.
- Is Bruker Corp profitable?
- Bruker Corp reported net income of -$8.6M for the fiscal year ending December 31, 2025.
- How many employees does Bruker Corp have?
- About 11,085 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Bruker Corp?
- Frank H. Laukien, Bruker’s President and CEO, as named in a 8-K filed November 4, 2026.
- Who is the CFO of Bruker Corp?
- Gerald N. Herman, EXECUTIVE VICE PRESIDENT, CFO, as named in a 4 filed August 18, 2026.
- Where is Bruker Corp headquartered?
- Billerica, MA.
- What is Bruker Corp's stock ticker?
- BRKR, BRKRP on Nasdaq.
- What industry is Bruker Corp in?
- Laboratory Analytical Instruments, SIC code 3826.
- What is Bruker Corp's website?
- bruker.com.
- When does Bruker Corp report earnings next?
- February 2, 2027. Source: estimate_8k_pattern.
- Is Bruker Corp a public company?
- Yes. Bruker Corp files with the SEC under CIK 0001109354 and trades as BRKR.
- Who audits Bruker Corp?
- PricewaterhouseCoopers LLP, Boston, Massachusetts, as named in its latest annual report (10-K).
- How many shares of Bruker Corp are outstanding?
- 151.7 million shares as of July 29, 2025, from its 10-Q filed August 6, 2025.
- What is Bruker Corp's public float?
- $4.3B as of June 30, 2025, as reported on the cover of its 10-K filed February 27, 2026.
- How many business segments does Bruker Corp report?
- 4 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 5, 2026.
- When is Bruker Corp's annual shareholder meeting?
- May 21, 2026, per its proxy statement (DEF 14A) filed April 10, 2026.
- Have Bruker Corp insiders traded stock recently?
- Since September 12, 2025, officers and directors reported 15 open-market sales worth about $3.7M and 0 purchases on Forms 4 and 5. The most recent: Mark Munch (EXEC VP&PRES BRUKER NANO INC.) sold 2,000 shares on September 15, 2026.